Literature DB >> 24376934

Langerhans cell sarcoma: Response to radiotherapy.

Anna Lucas1, Eva González Barca2, Octavio Servitje3, Lina Abenoza2, María Noel González1, Miquel Macià1, Alicia Lozano1.   

Abstract

We present the case of a patient with progressive Langerhans cell sarcoma whose cutaneous lesions and nodal masses were treated with palliative radiotherapy. Response to relatively low doses of radiotherapy was both good and sustained. We recommend a dose of 15-30 Gy depending on treatment intention and volume of the lesions.

Entities:  

Keywords:  Langerhans cell sarcoma; Radiotherapy

Year:  2010        PMID: 24376934      PMCID: PMC3863322          DOI: 10.1016/j.rpor.2010.05.001

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  12 in total

1.  Langerhans cell sarcoma in a patient who underwent transplantation.

Authors:  C Diaz-Sarrio; N Salvatella-Danés; M Castro-Forns; A Nadal
Journal:  J Eur Acad Dermatol Venereol       Date:  2007-08       Impact factor: 6.166

2.  Chemotherapy for Langerhans cell sarcoma.

Authors:  Gen Ohara; Yasunori Funayama; Hiroaki Satoh; Kenzo Uchida
Journal:  J Orthop Sci       Date:  2009-03       Impact factor: 1.601

3.  Langerhans cell sarcoma involving gallbladder and peritoneal lymph nodes: a case report.

Authors:  Gang Zhao; Meng Luo; Zhi-Yong Wu; Qiang Liu; Bin Zhang; Run-Ling Gao; Zhi-Qi Zhang
Journal:  Int J Surg Pathol       Date:  2008-09-19       Impact factor: 1.271

4.  Langerhans cell sarcoma.

Authors:  Tammie Ferringer; Peter M Banks; John S Metcalf
Journal:  Am J Dermatopathol       Date:  2006-02       Impact factor: 1.533

Review 5.  Cutaneous Langerhans cell sarcoma: a case report and review of the literature.

Authors:  Olga L Bohn; Guillermo Ruiz-Argüelles; Leticia Navarro; Jesus Saldivar; Sergio Sanchez-Sosa
Journal:  Int J Hematol       Date:  2007-02       Impact factor: 2.490

6.  CD56/NCAM-positive Langerhans cell sarcoma: a clinicopathologic study of 4 cases.

Authors:  Takakazu Kawase; Minoru Hamazaki; Michinori Ogura; Yoshiaki Kawase; Toshihiko Murayama; Yoshio Mori; Hirokazu Nagai; Masatoshi Tateno; Takashi Oyama; Yoshikazu Kamiya; Hirofumi Taji; Yoshitoyo Kagami; Tomoki Naoe; Toshitada Takahashi; Yasuo Morishima; Shigeo Nakamura
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

7.  Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases.

Authors:  S A Pileri; T M Grogan; N L Harris; P Banks; E Campo; J K C Chan; R D Favera; G Delsol; C De Wolf-Peeters; B Falini; R D Gascoyne; P Gaulard; K C Gatter; P G Isaacson; E S Jaffe; P Kluin; D M Knowles; D Y Mason; S Mori; H-K Müller-Hermelink; M A Piris; E Ralfkiaer; H Stein; I-J Su; R A Warnke; L M Weiss
Journal:  Histopathology       Date:  2002-07       Impact factor: 5.087

8.  Primary cutaneous Langerhans cell sarcoma without Birbeck granules: indeterminate cell sarcoma?

Authors:  April Deng; Wendy Lee; Richard Pfau; Allan Harrington; John DiGiovani; Kyle A Prickett; David M Dare; John P Petrali
Journal:  J Cutan Pathol       Date:  2008-04-18       Impact factor: 1.587

9.  Leukemic transformation of Langerhans cell sarcoma.

Authors:  Kousuke Sumida; Yuya Yoshidomi; Hiroko Koga; Nobuo Kuwahara; Eijo Matsuishi; Kennosuke Karube; Koichi Oshima; Hisashi Gondo
Journal:  Int J Hematol       Date:  2008-03-22       Impact factor: 2.490

10.  ESHAP therapy effective in a patient with Langerhans cell sarcoma.

Authors:  Akihide Yoshimi; Keiki Kumano; Toru Motokura; Yutaka Takazawa; Satoshi Oota; Shigeru Chiba; Tsuyoshi Takahashi; Masashi Fukayama; Mineo Kurokawa
Journal:  Int J Hematol       Date:  2008-04-17       Impact factor: 2.490

View more
  1 in total

1.  Langerhans cell sarcoma arising from the root of tongue: a rare case.

Authors:  Jian-Jun Ren; Yu Zhao; Ming-Juan Liu; Guo Liu; Fei Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.